These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4542719)

  • 41. Malignant brain stem hyperthermia caused by submersion-related hypoxic encephalopathy.
    Wu CL; Chang IJ; Chen WJ; Lee CC
    Acta Anaesthesiol Scand; 2006 Mar; 50(3):396. PubMed ID: 16480487
    [No Abstract]   [Full Text] [Related]  

  • 42. Histopathological and neuropharmacological aspects of malignant hyperpyrexia.
    Ellis FR; Keaney NP; Harriman DG
    Proc R Soc Med; 1973 Jan; 66(1 Pt 1):66-7. PubMed ID: 4690061
    [No Abstract]   [Full Text] [Related]  

  • 43. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
    Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E
    Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782
    [No Abstract]   [Full Text] [Related]  

  • 44. [Death caused by malignant hyperthermia and approaches of the Italian judiciary].
    Barberis B; Marzano L
    Minerva Anestesiol; 1992 Oct; 58(10):1013-4. PubMed ID: 1461391
    [No Abstract]   [Full Text] [Related]  

  • 45. Suggested beginning of propofol infusion syndrome in an adult patient without lactacidosis: a case report.
    Fudickar A; Tonner PH; Mihaljovic Z; Dellien C; Weiler N; Scholz J; Bein B
    Eur J Anaesthesiol; 2008 Sep; 25(9):777-8. PubMed ID: 18471330
    [No Abstract]   [Full Text] [Related]  

  • 46. [Malignant hyperthermia during general anesthesia with rigor, myoglobinuria and disturbance of the blood coagulation mechanism].
    Oppermann C; Podlesch I; Purschke R
    Anaesthesist; 1971 Aug; 20(8):315-22. PubMed ID: 5570382
    [No Abstract]   [Full Text] [Related]  

  • 47. [Malignant hyperthermia].
    Popinigis J; Brucker RF; Taylor CA; Williams CH
    Pol Tyg Lek; 1972 Aug; 27(33):1290-3. PubMed ID: 4562245
    [No Abstract]   [Full Text] [Related]  

  • 48. [Creatininphosphokinase isoenzymes in anaesthesia-induced myoglobinuria (AIM) (author's transl)].
    Bernhardt D; Hörder MH
    Anaesthesist; 1981 Mar; 30(3):131-3. PubMed ID: 7224141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mandibular spasm and malignant hyperthermia].
    Pérez del Palomar Chavarri R; Goñi Belzunegui A; Domingo Cuevas I
    Rev Esp Anestesiol Reanim; 1986; 33(6):440-2. PubMed ID: 3823535
    [No Abstract]   [Full Text] [Related]  

  • 50. Elevated serum-creatine phosphokinase activity in a family with malignant hyperpyrexia.
    Zsigmond EK; Starkweather WH; Duboff GS; Flynn K
    Anesth Analg; 1972; 51(2):220-5. PubMed ID: 5062123
    [No Abstract]   [Full Text] [Related]  

  • 51. [Malignant hyperthermia: biochemico-metabolic aspects and personal experiences].
    Di Prospero S; Bianchi S; Di Lazzaro M; Camilli-Giammei T
    Clin Ter; 1984 Sep; 110(6):549-53. PubMed ID: 6238769
    [No Abstract]   [Full Text] [Related]  

  • 52. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Letter: Effect of ketamine on creatine phosphokinase levels.
    Meltzer HY; Hassan SZ; Moretti R; Hengeveld C; Bruckner D
    Lancet; 1975 May; 1(7917):1195-6. PubMed ID: 48818
    [No Abstract]   [Full Text] [Related]  

  • 54. Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: a report from the north american malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesthesiology; 2008 Apr; 108(4):603-11. PubMed ID: 18362591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Malignant hyperthermia during anesthesia and surgery].
    Vasil'chenko AI
    Klin Khir (1962); 1982 Dec; (12):47-8. PubMed ID: 7162059
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cardiac arrest following succinylcholine administration in neurosurgery].
    Gocho Y; Kaya K; Sato M
    Masui; 1969 Nov; 18(11):1129-33. PubMed ID: 5391327
    [No Abstract]   [Full Text] [Related]  

  • 57. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
    Bernhardt D
    Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Atypical malignant hyperthermia. A higher incidence than expected].
    Herrero E; Casinello F; de Stefano J; Fernández-Guisasola J; Pérez-Gallardo A
    Rev Esp Anestesiol Reanim; 1996 Jan; 43(1):42-3. PubMed ID: 8851836
    [No Abstract]   [Full Text] [Related]  

  • 59. [Raised creatine-kinase serum activity: not necessarily a sign of disease].
    Snoeck MM
    Ned Tijdschr Geneeskd; 2004 Jan; 148(3):154; author reply 155. PubMed ID: 14964030
    [No Abstract]   [Full Text] [Related]  

  • 60. [Malignant hyperthermia. The need for anesthesia in a patient manifesting this syndrome].
    Sina AG; Caramella F; Pagani L; Pietrobono P; Bragheri R
    Minerva Anestesiol; 1980 Nov; 46(11):1163-7. PubMed ID: 7231694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.